A comparative study on the antioxidant and glucose-lowering effects of curcumin and bisdemethoxycurcumin analog through in vitro assays

International Journal of Pharmacology

Volumn 6, Issue 5, 2010, Pages 664-669

  Sivabalan, S ^a   Anuradha, C V ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Anti oxidants; Curcumin analog; Diabetes; Gluconeogenesis; Oxidative stress

Indexed keywords

ANTIOXIDANT; CURCUMIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; FERROUS ASCORBATE; GLUCOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SYNTHESIS; GLUCONEOGENESIS; GLUCOSE ABSORPTION; IN VITRO STUDY; LIPID PEROXIDATION; LIVER CELL; LIVER HOMOGENATE; MALE; NONHUMAN; RAT;

EID: 77955666573     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.664.669     Document Type: Article

References (33)

1. Anand, P., S.G. Thomas, A.B. Kunnumakkara, C. Sundaram and K.B. Harikumar et al, 2008. Biological activities of curcumin and its analogues (Congeners) made by man and mother nature. Biochem. Pharmacol, 76: 1590-1611.
2. Anuradha, C.A. and J. Aukunuru, 2010. Preparation, characterisation and in vivo evaluation of bisdemethoxy curcumin analogue (BDMCA) nanoparticles. Trop. J. Pharm. Res., 9: 51-58.
3. Anusuya, S., V.P. Menon, V. Periaswamy and K.N. Rajasekaran, 2003. Protection of pancreatic beta-cell by the potential antioxidant bisohydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. J. Pharm. Pharm. Sci., 6: 327-333.
4. Arun, N. and N. Nalini, 2002. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum.Nutr., 57: 41-52.
5. Babu, K.V.D. and K.N. Rajasekharan, 1994. Simplified conditions for the synthesis of curcumin 1 and other curcuminoids. Organic Prep. Procedure Int., 26: 674-677.
6. Brouk, B., 1975. Plants Consumed by Man. Academic Press, London, ISBN: 012136450X, pp:54-65.
7. Cashman, J.R., S. Ghirmai, K.J. Abel, M. Fiala, 2008. Immune defects in Alzheimer's disease: New medications development. BMC Neurosci., 9: S13-S13.
8. Chakravarty, A.K., S.N. Chatterjee, H. Yasmin and T. Mazumder, 2009. Comparison or efficacy of turmeric and commercial curcumin in immunological functions and gene regulation. Int. J. Pharmacol., 5: 333-345.
9. Choudhary, D., D. Chandra and R.K. Kale, 1999. Modulation of radioresponse of glyoxalase system by curcumin. J. Ethnopharmacol., 64: 1-7.
10. Dhillon, N., B.B. Aggarwal, R.A. Newman, R.A. Wolff and A.B. Kunnumakkara et al, 2008. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res., 14: 4491-4499.
11. Fiala, M., P.T. Liu, A. Espinosa-Jeffrey, M.J. Rosenthal and G. Bernard et al, 2007. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc. Natl. Acad. Sci. USA., 104: 12849-12854.
12. Guo, L.Y., X.F. Cai, J.J. Lee, S.S. Kang and E.M. Shin et al, 2008. Comparison of suppressive effects of demethoxycurcumin and bisdemethoxycurcumin on expressions of inflammatory mediators in vitro and in vivo. Arch. Pharm. Res., 31: 490-496.
13. Hogberg, J., RE. Larson, A. Kristoferson and S. Orrenius, 1974. NADPH-dependent reductase solubilised from microsomes of peroxidation and its activity. Biochem. Biophys. Res. Commun., 56: 836-842.
14. Huizinga, M.M. and R.L. Rothman, 2006. Addressing the diabetes pandemic: A comprehensive approach. Indian J. Med. Res., 124: 481-484.
15. Ireson, C, S. Orr, D.J.L. Jones, R. Verschoyle and C.K. Lim et al, 2001. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production 1. Cancer Res., 61: 1058-1064.
16. Jovanovic, S.V., C.W. Boone, S. Steenken, M. Trinoga and R.B. Kaskey, 2001. How curcumin works preferentially with water soluble antioxidants? J. Am. Chem. Soc, 123: 3064-3068.
17. Kaneto, H., N. Katakami, D. Kawamori, T. Miyatsuka and K. Sakamoto et al, 2007. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal, 9: 355-366.
18. Kellett, G.L. and E. Brot-Laroche, 2005. Apical GLUT2: A major pathway of intestinal sugar absorption. Diabetes, 54: 3056-3062.
19. Lin, L., Q. Shi, A.K. Nyarko, K.F. Bastow and C.C. Wu et al, 2006. Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents. J. Med. Chem., 49: 3963-3972.
20. Majithiya, J.B. and R. Balaraman, 2005. Time-dependent changes in antioxidant enzymes and vascular reactivity of arota in streptozotocin-induced diabetic rats treated with curcumin. J. Cardiovasc. Pharmacol. 46: 697-705.
21. Mosley, C.A., D.C. Liotta and J.P. Snyder, 2007. Highly active anticancer curcumin analogues. Adv. Exp. Med. Biol, 595: 77-103.
22. Paramasivam, M., R. Poi and B. Hemanta, 2008. Quantitative determination of curcuminoids in turmeric powder by HPTLC technique. Curr. Sci., 95: 1529-1531.
23. Saltiel, A.R., 2001. New perspective into the molecular pathogenesis and treatment of type 2 diabetes. Cell, 104: 517-529.
24. Sandur, S.K., M.K. Pandey, B. Sung, K.S. Ahn and A. Murakami et al, 2007. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis, 28: 1765-1773.
25. Seo, K.I., M.S. Choi, U.J. Jung, H.J. Kim, J. Yeo, S.M. Jeon and M.K. Lee, 2008. Effect of curcumin supplementation on blood glucose, plasma insulin and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol. Nutr. Food Res., 52: 995-1004.
26. Sharma, R.A., W.P. Steward and A.J. Gescher, 2007. Pharmacokinetics and pharmacodynamics of curcumin. Adv. Exp. Med. Biol, 595: 453-470.
27. Simanjuntak, P., T.K. Prana, D. Wulandari, A. Dharmawan, E. Sumitro and M.R. Hendriyanto, 2010. Chemical studies on a curcumin analogue produced by endophytic fungal transformation. Asian J. Applied Sci., 3: 60-66.
28. Sreejayan-Rao, M.N., 1994. Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol, 46: 1013-1016.
29. Tajik, H., E. Tamaddonfard and N. Hamzeh-Gooshchi, 2007. Interaction between curcumin and opioid system in the formalin test of rats. Pak. J. Biol. Sci., 10: 2583-2586.
30. Tank, R., R. Sharma, T. Sharma and V.P. Dixit, 1990. Anti-diabetic activity of Curcuma longa in alloxan induced diabetic rats. Indian Drugs, 27: 587-589.
31. Tomren, M.A., M. Masson, T. Loftsson and H.H. Tonnesen, 2007. Studies on curcumin and curcuminoids 31. Symmetric and asymmetric curcuminoids: Stability, activity and complexation with cyclodextrin. Int. J. Pharm., 338: 27-34.
32. Weisberg, S.P., R. Leibel and D.V. Tortonello, 2008. Dietary curcumin significantly improves obesityassociated inflammation and diabetes in mouse models of diabesity. Endocrinology, 149: 3549-3558.
33. Youssef, K.M. and M.A. El-Sherbeny, 2005. Synthesis and antitumor activity of some curcumin analogs. Arch. Pharm., 338: 181-189.